Leonardo Lima Fuscaldi (Leonardo L Fuscaldi, Leonardo L Fuscaldi)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Experimental biology and medicine (Maywood, N.J.)

Pharmaceutics

Hospital Israelita Albert Einstein - HIAE

Universidade Federal de Minas Gerais - UFMG (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Israelita Albert Einstein - HIAE

Brazil

Postdoctoral fellow :: Instituto Israelita de Ensino e Pesquisa - IIEP

Education History

Universidade Federal de Minas Gerais - UFMG

Brazil

PHD :: Faculdade de Farmácia - FaFar

Universidade Federal de Minas Gerais - UFMG

Brazil

MSC :: Faculdade de Farmácia - FaFar

Universidade Federal de Minas Gerais - UFMG

Brazil

BSC :: Faculdade de Farmácia - FaFar

Publications

Cibele Rodrigues Toledo, Ahmed A Tantawy, Leonardo Lima Fuscaldi, Luciana Malavolta, Carolina de Aguiar Ferreira
EGFR- and Integrin α V β 3 -Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics. International journal of molecular sciences 25 (15) (2024)
Cibele Rodrigues Toledo, Ahmed A Tantawy, Leonardo Lima Fuscaldi, Luciana Malavolta, Carolina de Aguiar Ferreira
EGFR- and Integrin α V β 3 -Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics. International journal of molecular sciences 25 (15) (2024)
Ana Cláudia Camargo Miranda, Leonardo Lima Fuscaldi, Jorge Mejia Cabeza, Fábio Fernando Alves da Silva, Walter Miguel Turato, Fernanda Ferreira Mendonça, Solange Amorim Nogueira, Akemi Osawa, Lilian Yuri Itaya Yamaga, Luciana Malavolta, Marycel Rosa Felisa Figols de Barboza
Radiosynthesis Standardization and Preclinical Assessment of the [ 68 Ga]Ga-DOTA-Ubiquicidin 29-41 : A Translational Study Targeting Differential Diagnosis of Infectious Processes. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Ana Cláudia Camargo Miranda, Leonardo Lima Fuscaldi, Jorge Mejia Cabeza, Fábio Fernando Alves da Silva, Walter Miguel Turato, Fernanda Ferreira Mendonça, Solange Amorim Nogueira, Akemi Osawa, Lilian Yuri Itaya Yamaga, Luciana Malavolta, Marycel Rosa Felisa Figols de Barboza
Radiosynthesis Standardization and Preclinical Assessment of the [ 68 Ga]Ga-DOTA-Ubiquicidin 29-41 : A Translational Study Targeting Differential Diagnosis of Infectious Processes. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Ana Cláudia Camargo Miranda, Leonardo Lima Fuscaldi, Jorge Mejia Cabeza, Fábio Fernando Alves da Silva, Walter Miguel Turato, Fernanda Ferreira Mendonça, Solange Amorim Nogueira, Akemi Osawa, Lilian Yuri Itaya Yamaga, Luciana Malavolta, Marycel Rosa Felisa Figols de Barboza
Radiosynthesis Standardization and Preclinical Assessment of the [ 68 Ga]Ga-DOTA-Ubiquicidin 29-41 : A Translational Study Targeting Differential Diagnosis of Infectious Processes. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Danielle V Sobral, Leonardo Lima Fuscaldi, Ana Claudia R Durante, Fernanda F Mendonça, Larissa R de Oliveira, Ana Cláudia Camargo Miranda, Jorge Mejia Cabeza, Wagner R Montor, Marycel F de Barboza, Luciana Malavolta
Comparative Evaluation of Radiochemical and Biological Properties of 131 I- and [ 99m Tc]Tc(CO) 3 -Labeled RGD Analogues Planned to Interact with the α v β 3 Integrin Expressed in Glioblastoma. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Ana Cláudia Camargo Miranda, Sofia Nascimento Dos Santos, Leonardo Lima Fuscaldi, Luiza Mascarenhas Balieiro, Maria Helena Bellini, Maria Inês Calil Cury Guimarães, Elaine Bortoleti de Araújo
Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties. Pharmaceutics 13 (7) (2021)
Leonardo Lima Fuscaldi, Danielle V Sobral, Ana Claudia R Durante, Fernanda F Mendonça, Ana Cláudia Camargo Miranda, Marcelo L da Cunha, Luciana Malavolta, Jorge Mejia Cabeza, Marycel F de Barboza
Standardization of the [68Ga]Ga-PSMA-11 Radiolabeling Protocol in an Automatic Synthesis Module: Assessments for PET Imaging of Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Leonardo Lima Fuscaldi, Joaquim Teixeira de Avelar Júnior, Daniel Moreira Dos Santos, Daiane Boff, Vivian Louise Soares de Oliveira, Karla Aparecida Guimarães Gusmão Gomes, Rosana de Carvalho Cruz, Patrícia Luciana de Oliveira, Paula Prazeres Magalhães, Patricia Silva Cisalpino, Luiz de Macêdo Farias, Elaine Maria de Souza-Fagundes, Johannes Delp, Marcel Leist, Jarbas Magalhães Resende, Flávio Almeida Amaral, Adriano Monteiro de Castro Pimenta, Simone Odília Antunes Fernandes, Valbert Nascimento Cardoso, Maria Elena de Lima
Shortened derivatives from native antimicrobial peptide LyeTx I: In vitro and in vivo biological activity assessment. Experimental biology and medicine (Maywood, N.J.) 246 (4) (2020)
Ana Claudia R Durante, Danielle V Sobral, Ana Cláudia Camargo Miranda, Luciana Malavolta, Leonardo Lima Fuscaldi, Marycel Rosa Felisa Figols de Barboza
Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen®, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson's Disease. Pharmaceuticals (Basel, Switzerland) 12 (1) (2019)

Leonardo Lima Fuscaldi.css-eqlu8i{font-size:small;padding-left:4px;} (Leonardo L Fuscaldi, Leonardo L Fuscaldi)

Publication Activity (10 Years)

Top Topics

Top Venues

Leonardo Lima Fuscaldi (Leonardo L Fuscaldi, Leonardo L Fuscaldi)